Zhengye Biotechnology Holding (ZYBT) Income Statement: Revenue & Earnings

Zhengye Biotechnology Holding Income Statement Analysis

Revenue, earnings, and profit margins in millions CNY

Scale:

Scroll to see more

Zhengye Biotechnology Holding Limited income statement - Annual data in millions CNY
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Jun 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	116.36	186.36	186.36	211.65	260.27	214.07
Cost of Revenue	92.49	95.06	95.06	94.14	112.39	88.67
Gross Profit	23.87	91.30	91.30	117.51	147.88	125.39
Operating Expenses
Research & Development	18.01	12.79	12.79	11.90	13.42	11.37
Selling, General & Administrative	74.92	63.84	63.84	64.34	58.89	58.19
Operating Expenses	92.12	74.86	74.12	72.52	81.79	73.01
Operating Income	-68.25	16.44	17.17	44.99	66.09	52.38
Other Income/Expense
Interest Income	0.10	0.23	0.23	0.31	0.11	0.11
Interest Expense	3.40	4.04	4.04	-4.42	2.84	1.05
Other Income/Expense	-0.32	-2.05	1.03	-1.22	0.55	0.68
Income
Income Before Tax	-71.87	14.39	14.39	43.76	63.91	53.07
Income Tax Expense	11.10	0.92	0.92	6.25	8.17	6.60
Net Income	-69.78	11.31	11.31	31.46	46.74	38.96
Net Income - Continuous Operations	-82.97	11.31	13.47	31.46	55.74	38.96
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	-42.52	42.60	42.60	68.90	85.55	70.12
EBIT	-68.47	0.00	18.44	44.99	66.75	52.38
Depreciation & Amortization	25.96	24.16	24.16	23.91	18.80	16.01
Earnings Per Share
Basic EPS	-	-	-	1.00	1.00	1.00
Diluted EPS	-	-	-	1.00	1.00	1.00
Basic Shares Outstanding	0.00	47.17	47.17	45.67	45.67	45.67
Diluted Shares Outstanding	0.00	47.17	47.17	45.67	47.17	47.17